Comparison of gastric and small-bowel transit time between Lubiprostone, and placebo-controlled in healthy volunteers : a double-blind, placebo-controlled study by capsule endoscopy

Trial Profile

Comparison of gastric and small-bowel transit time between Lubiprostone, and placebo-controlled in healthy volunteers : a double-blind, placebo-controlled study by capsule endoscopy

Completed
Phase of Trial: Phase II

Latest Information Update: 17 May 2016

At a glance

  • Drugs Lubiprostone (Primary)
  • Indications Constipation; Irritable bowel syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 05 Aug 2014 Status changed from recruiting to completed.
    • 17 Jan 2014 According to University Hospital Medical Information Network - Japan record, status changed from not yet recruiting to recruiting.
    • 21 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top